Antonio L. Brucato
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 211 publications
Multiyear Recurrent Pericarditis Disease Duration: Clinical Outcomes After Cessation of Long-Term Interleukin-1 Pathway Inhibition Provide Insights for Chronic Management.
Journal: Journal of the American Heart Association
Published: July 28, 2026
Recurrent pericarditis in children: evidence, controversies, and emerging perspectives.
Journal: Current opinion in immunology
Published: June 04, 2026
Hydroxychloroquine for recurrent pericarditis.
Journal: European journal of internal medicine
Published: May 16, 2026
Association between canakinumab dose and long-term remission in Still's disease: insights from the AIDA network registry.
Journal: Frontiers in pharmacology
Published: April 03, 2026
The paradigm shift in corticosteroid therapy for idiopathic pericarditis: from high-dose regimens to precision therapy.
Journal: Clinical and experimental rheumatology
Published: March 31, 2026
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.
Journal: Seminars in arthritis and rheumatism
Published: February 24, 2026
Recurrent pericarditis in children: Clinical and therapeutic differences from adults.
Journal: International journal of cardiology
Published: February 07, 2026
Hydroxychloroquine for recurrent pericarditis: A multicentre observational study.
Journal: European journal of internal medicine
Published: January 13, 2026
2025 ESC Guidelines for the management of myocarditis and pericarditis
Journal: Giornale italiano di cardiologia (2006)
Published: December 24, 2025
IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis.
Journal: JAMA network open
Published: October 09, 2025
Last Updated: 09/26/2026